University of East Anglia Featured PhD Programmes
Aberdeen University Featured PhD Programmes
Lancaster University Featured PhD Programmes
"prostate"×
10 miles

prostate PhD Projects, Programs & Scholarships

We have 30 prostate PhD Projects, Programs & Scholarships

  • "prostate" ×
  • clear all
Order by 
Showing 1 to 15 of 30
  Towards the development of an effective vaccine for advanced prostate cancer
  Dr S McArdle
Applications accepted all year round

Funding Type

PhD Type

Prostate cancer is the second most frequent cancer in men. Patients with a localized disease are treated with local therapies such as prostatectomy or radiation therapy, whereas patients with metastatic disease are treated with androgen deprivation therapies (ADT).
  Transcriptional heterogeneity and resistance to therapy in prostate cancer
  Dr D. Goode
Applications accepted all year round

Funding Type

PhD Type

Androgen deprivation therapy (ADT) is a standard treatment for prostate cancer that works well in many cases but rapidly fails in others.
  Targeting perivascular macrophages to enhance the efficacy of immunotherapy in prostate cancer
  Prof CE Lewis, Dr M Muthana
Applications accepted all year round

Funding Type

PhD Type

Immunotherapies like checkpoint inhibitors do not work well in most prostate cancer patients, with only a small group showing durable responses.
  Ultrasensitive prostate cancer screening based on miRNA sensing from whole blood
  Prof J Edel
Applications accepted all year round

Funding Type

PhD Type

Current tests for the diagnosis, prognosis and stratification of prostate cancer suffer from two main drawbacks, being either invasive (requiring tissue biopsies) or inaccurate and therefore unreliable.
  The role of bone marrow fat in advance prostate cancer using bioengineered humanised models
  Dr N Bock
Application Deadline: 1 July 2020

Funding Type

PhD Type

SYNOPSIS. This highly innovative PhD project focuses on one of the key challenges in the fields of cancer research and translational medicine, which is to ‘make the mouse organism more human’.
  Is breast cancer more aggressive when developed by rural-dwellers compared to those living in the city?
  Prof P Murchie, Prof Z Miedzybrodzka, Prof V Speirs, Dr R Vieira
Application Deadline: 29 May 2020

Funding Type

PhD Type

BACKGROUND.
  Structure-property relationship in solid tumours – An integrated experimental and computational approach towards more effective early cancer diagnosis
  Dr Y Chen, Prof RL Reuben
Applications accepted all year round

Funding Type

PhD Type

Biological tissue often has unique three-dimensional hierarchical microstructures and morphologies, constantly evolving through their development and patho-physiological stages.
  Managing the effects of cancer: developing a nutrition intervention for the side and late effects of different treatment modalities for breast, prostate and bowel cancers (ICANEAT)
  Dr S MacLennan, Dr K Kiezebrink
Application Deadline: 29 May 2020

Funding Type

PhD Type

This is an innovative interdisciplinary project within the important area of supportive care. The student will join a small expert team within the Institute of Applied Health Sciences which has good links with NHS Grampian and UCAN (Urological Cancer Charity).
  mRNA translation reprogramming and metabolic re-wiring in response to ribosome-targeted therapies
  Prof R. Pearson, Dr J Kang
Applications accepted all year round

Funding Type

PhD Type

Increased synthesis and activity of ribosomes are associated with oncogenesis downstream of the major oncogenes including MYC, RAS and PI3K.
  Testing the function of immune suppressive cytokines and cells in bone metastasis
  Assoc Prof B Parker
Applications accepted all year round

Funding Type

PhD Type

Bone metastasis is a common occurrence in breast and prostate cancer that leads to patient morbidity and, in many cases, mortality.
  Mathematical Modelling of Cancer-Cell Transmigration Through Blood Vessels
  Dr F Spill
Applications accepted all year round

Funding Type

PhD Type

Cancer rarely kills through the primary tumour in which cancer arises, e.g. the prostate in prostate cancer. Instead, cancer cells may travel through the vasculature and colonialize distant organs – a process termed metastasis.
  An intelligent scheme to identify novel drug targets through analysing the DNA repairome in drug resistant cancer?
  Research Group: Biomedical Research Group
  Prof C Parris
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Transglutaminase 2 (TG2) as a novel cancer biomarker and target for chemotherapy
  Research Group: Biomedical Research Group
  Dr P Coussons, Dr C Pike
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  FGFR signalling in breast cancer
  Dr A Chioni
Applications accepted all year round

Funding Type

PhD Type

Growth factors are used during development to convey messages that tell cells to divide, survive, migrate and adopt a particular fate.
  Redeploying Rucaparib: Can PARP inhibitors alter deregulated cellular bioenergetics and overcome apoptosis resistance in cancer? (SF20/APP/WALDEN)
  Dr H Walden
Applications accepted all year round

Funding Type

PhD Type

Poly(ADP-ribose) polymerase inhibitors (PARPi) have received huge attention in oncology over recent years. They are FDA approved for use in BRCA1/2 defective breast and ovarian cancers with absent or dysfunctional homologous recombination repair function.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.